EPIPHORA

Clinical trials for EPIPHORA explained in plain language.

Never miss a new study

Get alerted when new EPIPHORA trials appear

Sign up with your email to follow new studies for EPIPHORA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Terminated 1

Could a Low-Dose eye drop stop constant watery eyes?

Symptom relief Recruiting now

This trial tests whether low-dose atropine eye drops can reduce excessive tearing (epiphora) in adults. Participants use one of two strengths (0.005% or 0.01%) in their affected eye(s) for one week. The study compares how well each dose works and monitors for any side effects.

Matched conditions: EPIPHORA

Phase: PHASE2 • Sponsor: Rehan Ahmed • Aim: Symptom relief

Last updated Jul 02, 2026 00:00 UTC

EPIPHORA

Get alerted when new EPIPHORA trials appear

Could a Low-Dose eye drop stop constant watery eyes?